Elan Mulls Royalty Pharma Takeover and 2 Other Hot Stocks to Watch

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Elan Corporation (NYSE:ELN): Current price $13.36

On Friday, Royalty Pharma announced, through Rule 2.5 of the Irish Takeover Rules, its intention to further raise its offer for Elan Corporation to $13 per share in cash, alongside a contingent value right worth as much as $2.50 per share. Elan’s board acknowledged the revised offer, and said that it will as before assess the Royalty Pharma announcement, and advise its shareholders accordingly. Meanwhile, Elan shareholders are strongly advised to take no action regarding the offer.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ELN

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business